Latest ebit for TMPMW: $-410M, below the sector sector average of $-63M.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2022
Trailing 12 months ending Jun 30, 2022
Turmeric Acquisition - Warrants (20/10/2025) posts a EBIT of $-410M as of June 2022. That compares with $-830K in the prior-year period — down 49182.7% year over year. That is below the sector sector average of $-63M. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Turmeric Acquisition - Warrants (20/10/2025)'s EBIT was $-830K. The latest reading is $-410M — a 49182.7% year-over-year decrease (period ending June 2022). Use the history and growth charts on this page for a longer lookback.
For its sector stocks, a EBIT near $-63M is typical. Turmeric Acquisition - Warrants (20/10/2025)'s $-410M is lower that level. That is roughly 557.2% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
EBIT is one piece of Turmeric Acquisition - Warrants (20/10/2025)'s financial statement story. At $-410M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for TMPMW's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $-63M), and (3) consistency with growth and profitability. This page covers the first two; Turmeric Acquisition - Warrants (20/10/2025)'s other metric pages and overview cover the third.